Sumbal Babar

Sumbal Babar practices at Carilion Roanoke Memorial Hospital in Roanoke, Virginia, part of Carilion Clinic.

Sumbal Babar's NPI, 1356834808, was assigned on June 10, 2018. Sumbal Babar holds Virginia license 0101276555.

Sumbal Babar's primary practice is Carilion Roanoke Memorial Hospital, at 1906 Belleview Avenue, SE, Roanoke, VA 24014 in Roanoke City. The practice phone is (540) 981-7000.

Sumbal Babar's primary practice is Carilion Roanoke Memorial Hospital in Roanoke, Virginia, part of Carilion Clinic. Sumbal Babar is also affiliated with Carilion New River Valley Medical Center. The medical group on file is Carilion Clinic. Dmand AI also links Sumbal Babar to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sumbal Babar practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Sumbal Babar's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Sumbal Babar's licenses on file in 2 states: Virginia and Tennessee.

CMS data shows 151 Medicare services from Sumbal Babar across 5 procedure codes in 2024, for 123 Medicare patients. Medicare paid $13,186 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 123 Medicare patients who saw Sumbal Babar in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sumbal Babar's median patient age at 60, with 44% women.

In 2024, Sumbal Babar wrote 312 Medicare Part D claims for 76 patients. 46% of them were for generic drugs. CMS names the drug for 198 of them, across 9 drugs with 11 or more claims each, at $569,247 in total drug cost. In 2023, CMS named 33 claims across 1 drug.

Sumbal Babar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Sumbal Babar, published from 2016 to 2025. 2017 was the busiest year, with 2. Sumbal Babar has published most often in Cureus. Sumbal Babar's most frequent co-authors are Bara Ibrahim El Kurdi, MD, Salman Assad, MD and Zaid Imam, MD.

CMS Open Payments shows 1 general payment to Sumbal Babar from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $37.